N-(3-(Benzylamino)-3-oxopropyl)-N-(4-(hydroxycarbamoyl)benzyl)-4-methoxybenzamide

ID: ALA4549502

PubChem CID: 155550805

Max Phase: Preclinical

Molecular Formula: C26H27N3O5

Molecular Weight: 461.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)N(CCC(=O)NCc2ccccc2)Cc2ccc(C(=O)NO)cc2)cc1

Standard InChI:  InChI=1S/C26H27N3O5/c1-34-23-13-11-22(12-14-23)26(32)29(18-20-7-9-21(10-8-20)25(31)28-33)16-15-24(30)27-17-19-5-3-2-4-6-19/h2-14,33H,15-18H2,1H3,(H,27,30)(H,28,31)

Standard InChI Key:  PKTYWCZLVZZUAK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
   19.7639  -14.0443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7627  -14.8639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4708  -15.3023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1804  -14.8929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1776  -14.0702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4690  -13.6650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8888  -15.3004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8901  -16.1176    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5959  -14.8907    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3042  -15.2981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0561  -13.6654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3485  -14.0742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6407  -13.6657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6405  -12.8485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9327  -12.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9325  -11.6229    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2250  -12.8489    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3487  -14.8913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6410  -15.3001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0565  -15.2998    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6401  -11.2142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3479  -11.6226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3430  -12.4405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0499  -12.8489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7585  -12.4401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7557  -11.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0482  -11.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9347  -14.8879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2276  -15.2960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2274  -16.1140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9401  -16.5223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6444  -16.1119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5203  -16.5237    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8119  -16.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  1 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 12 18  1  0
 18 19  1  0
 18 20  2  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 19 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 19  1  0
 30 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4549502

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase 1 (10854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHP-134 (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMR-32 (1082 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-N-AS (237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NB1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
G55T2 (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.52Molecular Weight (Monoisotopic): 461.1951AlogP: 3.16#Rotatable Bonds: 10
Polar Surface Area: 107.97Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.05CX Basic pKa: CX LogP: 2.54CX LogD: 2.53
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.32Np Likeness Score: -1.26

References

1. Reßing N, Marquardt V, Gertzen CGW, Schöler A, Schramm A, Kurz T, Gohlke H, Aigner A, Remke M, Hansen FK..  (2019)  Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activity.,  10  (7): [PMID:31391882] [10.1039/C8MD00454D]

Source